Home » Cipla Breached Patent Rights by Slashing Cancer Drug Price: Bayer Pharma
Cipla Breached Patent Rights by Slashing Cancer Drug Price: Bayer Pharma
German pharma major Bayer has charged that Indian generic drugmaker Cipla had breached its patent rights by slashing the price of a generic version of its patent-protected cancer drug Nexavar last week.
The Economic Times
The Economic Times
Upcoming Events
-
07May
-
14May
-
30May